Philip Morris International (PMI) Listed among 100 Top Patent Filers by the European Patent Office
The European Patent Office (EPO) published today its Annual Report including the list of top 100 patent applicants for 2016, with Philip Morris International Inc. (“PMI”) (NYSE / Euronext Paris: PM) ranked 63rd. PMI is the only tobacco company on the list.
PMI is committed to a smoke-free future, where non-combustible alternatives replace cigarettes to the benefit of smokers, public health and society at large.
PMI’s patent portfolio includes over 1800 patents granted and almost 4000 pending applications published for intellectual property generated during the development of our smoke-free products. They include a wide range of innovations, such as technologies to precisely heat tobacco instead of burning it, new ways to heat liquids in e-cigarettes and manufacturing processes.
Michele Cattoni, PMI’s VP Technology and Operations for smoke-free products said: “Developments in technology and science are key to our commitment to provide all adult smokers a range of better alternatives to cigarettes. Our scientists are inventing new ways to deliver a satisfying experience to smokers without burning tobacco. Our patents are tangible evidence of our progress towards a smoke-free future, where cigarettes will be replaced by non-combustible products.”
Since 2008, PMI has hired over 400 scientists and experts and invested over USD 3 billion in research, product development and scientific substantiation for smoke-free products. The Company openly shares its scientific methodologies and findings for independent third-party review and verification, available on PMIScience.com. All research to date on its most advanced smoke-free product, IQOS , clearly indicates that it is likely to present less risk of harm than continued smoking. Over 1.4 million smokers have already fully switched to it.
To learn more about how PMI is designing a smoke-free future, please visit the new company website at www.pmi.com .
Philip Morris International Inc.
Philip Morris International Inc. (PMI) is the world’s leading international tobacco company, with six of the world's top 15 international brands and products sold in more than 180 markets. In addition to the manufacture and sale of cigarettes, including Marlboro , the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of Reduced-Risk Products (RRPs). RRPs is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and industry-leading scientific substantiation, PMI aims to provide an RRP portfolio that meets a broad spectrum of adult smoker preferences and rigorous regulatory requirements. For more information, see www.pmi.com and www.pmiscience.com .
Philip Morris International media office
T: +41 (0)58 242 4500
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
FOCP19.11.2017 17:33 | pressemeddelelse
Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life
ASTRAZENECA19.11.2017 00:02 | pressemeddelelse
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases
ASTRAZENECA18.11.2017 19:22 | pressemeddelelse
New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer
CHINA-HI-TECH-FAIR18.11.2017 10:13 | pressemeddelelse
Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled
NY-MADISON-REALTY17.11.2017 17:22 | pressemeddelelse
Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn
NCARDIA17.11.2017 13:33 | pressemeddelelse
Ncardia Announces Completion of €10.5M Investment Round
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum